Verena Karsten
- Molecular Biology top 10%
- Surgery top 10%
- Oncology top 10%
- Nephrology top 5%
- Cancer Research top 10%
- Co-authors
- Akshay VaishnawJared GollobBrian R. BettencourtJoshua R. VestJoseph ChiesaSaraswathy V. NochurRenta HutabaratPushkal Garg
- Topics
- Amyloidosis: Diagnosis, Treatment, Outcomes (14 papers)Peptidase Inhibition and Analysis (6 papers)Cardiomyopathy and Myosin Studies (4 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Verena Karsten
23 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Molecular Biology 1.2k
- Surgery 326
- Oncology 266
- Nephrology 204
- Cancer Research 204
Countries citing papers authored by Verena Karsten
This map shows the geographic impact of Verena Karsten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Karsten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Karsten more than expected).
Fields of papers citing papers by Verena Karsten
This network shows the impact of papers produced by Verena Karsten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Karsten. The network helps show where Verena Karsten may publish in the future.
Co-authorship network of co-authors of Verena Karsten
This figure shows the co-authorship network connecting the top 25 collaborators of Verena Karsten. A scholar is included among the top collaborators of Verena Karsten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Karsten. Verena Karsten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 27 | |
| 3 | 80 | |
| 4 | 11 | |
| 5 | 49 | |
| 6 | 130 | |
| 7 | 15 | |
| 8 | Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosisbreakdown → | 316 |
| 9 | 13 | |
| 10 | 3 | |
| 11 | 68 | |
| 12 | 157 | |
| 13 | 120 | |
| 14 | 75 | |
| 15 | 12 | |
| 16 | 3 | |
| 17 | 55 | |
| 18 | Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trialbreakdown → | 467 |
| 19 | Results of a phase 2b multi-center trial of ALN-RSV01 in respiratory syncytial virus (RSV)-infected lung transplant patients | 15 |
| 20 | Results of a phase 2b multi-center, randomized, double-blind, placebo-controlled study of an RNAi therapeutic, ALN-RSV01, in respiratory syncytial virus (RSV)-infected lung transplant patients | 3 |
About Verena Karsten
Verena Karsten is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Genetics, having authored 23 papers that have together received 1.7k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (14 papers), Peptidase Inhibition and Analysis (6 papers) and Cardiomyopathy and Myosin Studies (4 papers). The work is most often cited by research in Nephrology (204 citations), Molecular Biology (1.2k citations) and Cancer Research (204 citations). Verena Karsten has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Akshay Vaishnaw, Jared Gollob, Brian R. Bettencourt, Joshua R. Vest, Joseph Chiesa, Saraswathy V. Nochur, Renta Hutabarat, Pushkal Garg, Valerie A. Clausen and Mathew S. Maurer. Their work appears in journals such as The Lancet, Circulation and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.